Morphosys Net Loss Narrows as Lower Costs Offset Sales Decline
By Andrea Figueras Morphosys reported narrowed net and operating losses for the second quarter thanks to lower costs that offset a decline in revenue. The...
Andrea Figueras Article Normal Biotechnology Services Healthcare Life Sciences Financial Performance Sales Figures
Source: marketwatch.com